10-Q - BrightSpring Health Services, Inc. (0001865782) (Filer)

8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)

DEFA14A - BrightSpring Health Services, Inc. (0001865782) (Filer)

DEF 14A - BrightSpring Health Services, Inc. (0001865782) (Filer)

8-K/A - BrightSpring Health Services, Inc. (0001865782) (Filer)

10-K - BrightSpring Health Services, Inc. (0001865782) (Filer)

8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)

8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)

144 - BrightSpring Health Services, Inc. (0001865782) (Subject)

SCHEDULE 13G/A - BrightSpring Health Services, Inc. (0001865782) (Subject)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the first quarter ended March 31, 2025, and increased Revenue and Adjusted EBITDA1 guidance. Financial Highlights(note: all figures exclude the Community Living business) Net Revenue of $2,878 million, up 25.9% compared to $2,286 million in the first quarter of 2024.Net Income from Continuing Operations of $9.2 million, compared to Net Loss from Continuing Operations of $56.0 million in the first quarter of 2024.Adjusted EBITDA1 of

LOUISVILLE, Ky., April 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its first quarter 2025 financial results on Friday, May 2, 2025, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference call.

LOUISVILLE, Ky., March 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the fourth quarter and full year ended December 31, 2024, and increased revenue and Adjusted EBITDA¹ guidance. Financial Highlights Fourth quarter net revenue of $3,053 million, up 28.6% compared to $2,375 million in the fourth quarter of 2023.Fourth quarter net income of $15.4 million, compared to net loss of $7.2 million in the fourth quarter of 2023.Fourth quarter Adjusted EBITDA¹ of $167 million, up 17.4% versus $143 million i

LOUISVILLE, Ky., March 05, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) a leading provider of home and community-based pharmacy and health services for complex populations, today announced the promotion of Jennifer Phipps to Chief Financial Officer. She will succeed Jim Mattingly, current Chief Financial Officer, effective as of March 4, 2025. Ms. Phipps' experience at BrightSpring Health Services spans eight years, and she currently serves as Chief Accounting Officer and Principal Accounting Officer, as well as Chief Financial Officer of BrightSpring's Home Health and Hospice segment and Senior Vice President of Treasury, Ris

LOUISVILLE, Ky., Feb. 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its fourth quarter and full year 2024 financial results on Thursday, March 6, 2025, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to th

Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and Care Management strategic prioritiesProceeds from the sale will be used to reduce debt resulting in accelerated deleveraging while also increasing capital availabilityDivesture expected to increase Company Revenue and EBITDA Growth Rates and Cash Conversion, as well as Provider Services Revenue and EBITDA Growth Rates and Margin1Company reports 2024 preliminary Revenue and Adjusted EBITDA, above prior guidance issued on November 1, 2024, and initiates 2025 guidance excluding Community Living LOUISVILLE, Ky., Jan.

LOUISVILLE, Ky., Dec. 11, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, completed the successful refinancing of all of its $2.55 billion Term Loan B facility due February 2031, through its subsidiary Phoenix Guarantor Inc. BrightSpring incurred no additional indebtedness as a result of the transaction. The Company's refinanced facility was repriced at SOFR +250 basis points, vs. the prior issuance at SOFR +325 basis points. The repricing reduced the applicable interest rate on the outstanding term loan by 75 basis points, representing an es

LOUISVILLE, Ky., Nov. 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "BrightSpring Health Services") (NASDAQ:BTSG) is proud of its specialty pharmacy partner, Onco360®, for being selected as the national pharmacy partner for multiple medications approved to treat advanced cancers and blood disease. "Our partner Onco360 is rapidly bringing innovative medicines and treatments to market to help improve the lives of patients living with once untreatable, rare diseases," said BrightSpring's President and CEO, Jon Rosseau. "We are proud of their work to distribute breakthrough therapies and treatments to life-threatening diseases, expanding available care options,

LOUISVILLE, Ky., Nov. 21, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that Company management will participate at two upcoming virtual investor conferences. BTIG Virtual Digital Health Forum Panel on Monday, November 25th at 9:00AM ET Bank of America Virtual Home Care Conference 2024Fireside Chat on Tuesday, December 10th at 2:10PM ET A live and archived webcast of the Bank of America Home Care Conference Fireside Chat will be available on the "Event & Presentations" section of the BrightSpring investor relations website at https://ir.brightspringhealth.com/. About BrightSpring Health Services Brig

LOUISVILLE, Ky., Nov. 06, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "BrightSpring Health Services") (NASDAQ:BTSG) is proud that CareMed, a BrightSpring company and leading independent Specialty Pharmacy, was selected by Eisai to be the national specialty pharmacy provider for Leqembi®, a cutting-edge treatment for Alzheimer's disease. "We're proud of the work CareMed is doing with manufacturers and prescribers to improve and extend the lives of patients living with mild cognitive impairment and dementia, bringing more treatment options to Alzheimer's disease," said BrightSpring's President and CEO, Jon Rousseau. "CareMed's partnership with Eisai shows their

LOUISVILLE, Ky., Sept. 30, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ:BTSG), a leading provider of home- and community-based health services for complex populations, today announced that Dr. Steve Miller was appointed as a Class II member of the Board of Directors. Dr. Miller will also serve as a member of the Board's Audit Committee and as the chair of the Board's Quality & Compliance and Governance Committee. As a nationally recognized advocate for greater access, affordability, and excellence in healthcare, Dr. Miller brings decades of experience to the Company as a medical researcher, clinician, and administrator across numerous hea

LOUISVILLE, Ky., April 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced that on April 24, 2024, BrightSpring appointed Timothy A. Wicks as a new member of the Board of Directors. Mr. Wicks will assume his new role effective immediately, bringing the Company's total Board of Directors to seven members, including two independent directors. Mr. Wicks brings over 20 years of executive leadership experience in the healthcare industry to BrightSpring's Board of Directors, including his most recent role as Executive Vice President

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4/A - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)

CJS Securities initiated coverage of BrightSpring Health Services with a rating of Market Outperform

KeyBanc Capital Markets initiated coverage of BrightSpring Health Services with a rating of Sector Weight

BTIG Research initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $15.00

HSBC Securities initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $13.00

Deutsche Bank upgraded BrightSpring Health Services from Hold to Buy and set a new price target of $11.50

Guggenheim initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $15.00

Leerink Partners initiated coverage of BrightSpring Health Services with a rating of Outperform and set a new price target of $15.00

UBS initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $15.00

BofA Securities initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $14.00

UBS initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $14.00

SC 13G - BrightSpring Health Services, Inc. (0001865782) (Subject)

SC 13G - BrightSpring Health Services, Inc. (0001865782) (Subject)

SC 13G - BrightSpring Health Services, Inc. (0001865782) (Subject)

SC 13D - BrightSpring Health Services, Inc. (0001865782) (Subject)